Yan Wei

1.1k total citations · 1 hit paper
28 papers, 866 citations indexed

About

Yan Wei is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Yan Wei has authored 28 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Biomaterials and 7 papers in Oncology. Recurrent topics in Yan Wei's work include Nanoparticle-Based Drug Delivery (11 papers), Extracellular vesicles in disease (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Yan Wei is often cited by papers focused on Nanoparticle-Based Drug Delivery (11 papers), Extracellular vesicles in disease (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Yan Wei collaborates with scholars based in China, United States and Australia. Yan Wei's co-authors include Jiacan Su, Shihao Sheng, Can Xu, Yong Gan, Xiao Chen, Fengjin Zhou, Shiyan Guo, Ke Xu, Xinxin Zhang and Yu-Xi Wang and has published in prestigious journals such as ACS Nano, Biomaterials and Advanced Functional Materials.

In The Last Decade

Yan Wei

28 papers receiving 862 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases

2023 129 citations Jiawei Guo, Fuxiao Wang et al. Cell Reports Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yan Wei China	19	381	296	269	143	114	28	866
Fangyuan Xie China	20	362 1.0×	231 0.8×	232 0.9×	165 1.2×	114 1.0×	36	935
Jung Min Shin South Korea	15	382 1.0×	393 1.3×	272 1.0×	118 0.8×	88 0.8×	27	975
Yuan Yu China	16	411 1.1×	327 1.1×	330 1.2×	183 1.3×	132 1.2×	46	1.1k
Isaac M. Adjei United States	15	253 0.7×	328 1.1×	188 0.7×	144 1.0×	161 1.4×	22	848
Jueun Jeon South Korea	18	269 0.7×	482 1.6×	316 1.2×	91 0.6×	174 1.5×	27	913
Ali Fotouhi Iran	11	248 0.7×	206 0.7×	168 0.6×	158 1.1×	94 0.8×	15	719
Huining He China	19	573 1.5×	499 1.7×	530 2.0×	124 0.9×	135 1.2×	44	1.3k
Biaotong Huang China	13	419 1.1×	244 0.8×	135 0.5×	158 1.1×	106 0.9×	17	839
Seung Rim Hwang South Korea	16	569 1.5×	202 0.7×	185 0.7×	98 0.7×	56 0.5×	38	1.0k

Countries citing papers authored by Yan Wei

Since Specialization

Citations

This map shows the geographic impact of Yan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Wei more than expected).

Fields of papers citing papers by Yan Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Wei. The network helps show where Yan Wei may publish in the future.

Co-authorship network of co-authors of Yan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Wei. A scholar is included among the top collaborators of Yan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Wei. Yan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Jing, Yunlong Cheng, Kang Qian, et al.. (2025). siRNA-Encapsulated Biomimetic Liposomes Effectively Inhibit Tumor Cells’ Hexosamine Biosynthesis Pathway for Attenuating Hyaluronan Barriers to Pancreatic Cancer Chemotherapy. ACS Nano. 19(8). 7928–7947. 8 indexed citations

Wei, Yan, et al.. (2025). Human placental mesenchymal stem cells regulate the antioxidant capacity of CD8+PD-1+ T cells through the CD73/ADO/Nrf2 pathway to protect against liver damage in mice with acute graft-versus-host disease. Molecular Immunology. 179. 71–83. 2 indexed citations

Yan, Jing, Miaomiao Wang, Dagui Chen, et al.. (2024). SiATG5-loaded cancer cell membrane-fused liposomes induced increased uptake of albumin-bound chemotherapeutics by pancreatic cancer cells. Journal of Controlled Release. 367. 620–636. 22 indexed citations

Wei, Yan, et al.. (2024). Enzyme-responsive liposomes for controlled drug release. Drug Discovery Today. 29(7). 104014–104014. 30 indexed citations

Zhou, Fengjin, Guangfeng Li, Yan Wei, et al.. (2024). Cyaonoside A-loaded composite hydrogel microspheres to treat osteoarthritis by relieving chondrocyte inflammation. Journal of Materials Chemistry B. 12(17). 4148–4161. 9 indexed citations

Cheng, Yunlong, Minjun Xu, Kang Qian, et al.. (2024). Carcinoma–Astrocyte Gap Junction Interruption by a Dual-Targeted Biomimetic Liposomal System to Attenuate Chemoresistance and Treat Brain Metastasis. ACS Nano. 18(50). 34107–34125. 5 indexed citations

Zhou, Dongyang, Yan Wei, Shihao Sheng, et al.. (2024). MMP13-targeted siRNA-loaded micelles for diagnosis and treatment of posttraumatic osteoarthritis. Bioactive Materials. 37. 378–392. 27 indexed citations

Zhou, Guangyin, Ruiyang Li, Shihao Sheng, et al.. (2024). Organoids and organoid extracellular vesicles-based disease treatment strategies. Journal of Nanobiotechnology. 22(1). 679–679. 18 indexed citations

Gao, Qianmin, Shihao Sheng, Fengjin Zhou, et al.. (2024). Smart osteoclasts targeted nanomedicine based on amorphous CaCO3 for effective osteoporosis reversal. Journal of Nanobiotechnology. 22(1). 153–153. 26 indexed citations

10.

Guo, Jiawei, Fuxiao Wang, Yan Hu, et al.. (2023). Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases. Cell Reports Medicine. 4(1). 100881–100881. 129 indexed citations breakdown →

11.

Cao, Jinxu, Jing Wu, Peng Yang, et al.. (2023). Dual Enzyme Cascade-Activated Popcorn-Like Nanoparticles Efficiently Remodeled Stellate Cells to Alleviate Pancreatic Desmoplasia. ACS Nano. 17(20). 19793–19809. 12 indexed citations

12.

Cheng, Yunlong, Xiaoying Pang, Jing Wu, et al.. (2023). Medium-chain triglyceride-stabilized docetaxel-loaded HSA nanoparticles effectively inhibited metastatic non-small cell lung cancer. Drug Delivery and Translational Research. 13(11). 2869–2884. 4 indexed citations

13.

Yan, Jing, Hao Zhang, Guangfeng Li, et al.. (2023). Lipid nanovehicles overcome barriers to systemic RNA delivery: Lipid components, fabrication methods, and rational design. Acta Pharmaceutica Sinica B. 14(2). 579–601. 19 indexed citations

14.

Xie, Fangyuan, Kaichun Li, You Yin, et al.. (2022). Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy via inhibiting tumor-associated macrophage M2 polarization. Acta Pharmaceutica Sinica B. 12(7). 3124–3138. 72 indexed citations

15.

Guo, Shiyan, Di Sun, Dalong Ni, et al.. (2020). Smart Tumor Microenvironment‐Responsive Nanotheranostic Agent for Effective Cancer Therapy. Advanced Functional Materials. 30(17). 47 indexed citations

16.

Wei, Yan, Sha Song, Yu-Xi Wang, et al.. (2020). MT1‐MMP‐Activated Liposomes to Improve Tumor Blood Perfusion and Drug Delivery for Enhanced Pancreatic Cancer Therapy. Advanced Science. 7(17). 1902746–1902746. 53 indexed citations

17.

Wei, Yan, Yu-Xi Wang, Dengning Xia, et al.. (2017). Thermosensitive Liposomal Codelivery of HSA–Paclitaxel and HSA–Ellagic Acid Complexes for Enhanced Drug Perfusion and Efficacy Against Pancreatic Cancer. ACS Applied Materials & Interfaces. 9(30). 25138–25151. 61 indexed citations

18.

Bai, Shuzhan, et al.. (2016). Construction of Typical Driving Cycle of Bus Based on Clustering and Markov Chain. 29(11). 169. 2 indexed citations

19.

Wei, Yan, Aifeng Zou, Shuang Zhang, et al.. (2014). A Novel Combined Micellar System of Lapatinib and Paclitaxel with Enhanced Antineoplastic Effect Against Human Epidermal Growth Factor Receptor-2 Positive Breast Tumor In Vitro. Journal of Pharmaceutical Sciences. 104(1). 165–177. 25 indexed citations

20.

Gao, Huile, Yuchen Wang, Chen Chen, et al.. (2013). Incorporation of lapatinib into core–shell nanoparticles improves both the solubility and anti-glioma effects of the drug. International Journal of Pharmaceutics. 461(1-2). 478–488. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact